Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
Abstract Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devices have been developed to detect G6PD def...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2021-08-01
|
| Colección: | Infectious Diseases of Poverty |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s40249-021-00889-2 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
